TrialJournal of atherosclerosis and thrombosis2022

Pitavastatin-Incorporated Nanoparticles for Chronic Limb Threatening Ischemia: A Phase I/IIa Clinical Trial.

Takuya Matsumoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.